Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Urology meeting highlights prostate, bladder cancers.

Fillon M.

J Natl Cancer Inst. 2012 Sep 19;104(18):1348-9. Epub 2012 Sep 14. No abstract available.

PMID:
22984200
2.

[Urologists introduce a new round of prostate specific antigen discussion].

[No authors listed]

Aktuelle Urol. 2013 Jul;44(4):257-8. doi: 10.1055/s-0033-1351764. Epub 2013 Jul 31. German. No abstract available.

PMID:
23904120
3.

Congress of the American Society of Urology (ASU), San Antonio (Texas), May 15-20, 1993.

Boiteux JP.

Bull Cancer. 1994 Jan;81(1):70-3. French. No abstract available.

PMID:
7524820
4.

New PSA guidelines discourage overscreening.

Peres J.

J Natl Cancer Inst. 2012 Jan 4;104(1):8-9. doi: 10.1093/jnci/djr539. Epub 2011 Dec 14. No abstract available.

PMID:
22173585
5.

Re: an empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.

Vickers AJ.

J Natl Cancer Inst. 2011 Nov 2;103(21):1635-6. doi: 10.1093/jnci/djr353. Epub 2011 Sep 16. No abstract available.

PMID:
21926376
6.

Re: an empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.

Loeb S, Metter EJ, Carter HB.

J Natl Cancer Inst. 2011 Nov 2;103(21):1636-7; author reply 1637. doi: 10.1093/jnci/djr352. Epub 2011 Sep 16. No abstract available.

PMID:
21926375
7.

Prostate cancer: is the PSA test the answer?

Berlin B.

N J Med. 1998 Mar;95(3):53-5. Review. No abstract available.

PMID:
16013148
8.

[Detection of prostate cancer. German guideline recommends opportunist screening].

Arnheim K.

MMW Fortschr Med. 2010 Sep 30;152(39):12-3. German. No abstract available.

PMID:
21058430
9.

States renewing attention to prostate cancer.

Rossiter C.

NCSL Legisbrief. 2012 Sep;20(36):1-2. No abstract available.

PMID:
23072022
10.

Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations.

Zavaski ME, Meyer CP, Sammon JD, Hanske J, Gupta S, Sun M, Trinh QD.

JAMA Intern Med. 2016 Apr;176(4):546-7. doi: 10.1001/jamainternmed.2015.7901. No abstract available.

11.

Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.

Welch HG, Fisher ES, Gottlieb DJ, Barry MJ.

J Natl Cancer Inst. 2007 Sep 19;99(18):1395-400. Epub 2007 Sep 11.

PMID:
17848671
12.

[The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].

Bratt O, Damber JE, Kärvinge C, Malm T, Hensjö LO, Hyttsten E.

Lakartidningen. 2008 Feb 20-26;105(8):524-8. Swedish. No abstract available.

PMID:
18363292
13.

Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

Hoeltl W, Müller MM, Lunglmayr G.

J Urol. 2005 Jun;173(6):2205; author reply 2205-6. No abstract available.

PMID:
15879895
14.

Why prostate cancer screening is necessary.

Witte MN, Lindaman BD, Rosinsky DE.

S D Med. 2015;Spec No:88-91. Review. No abstract available.

PMID:
25985616
15.

General adherence to guideline recommendations on initial diagnosis of bladder cancer in the United States and influencing factors.

Karl A, Adejoro O, Saigal C, Konety B; Urologic Diseases in America Project.

Clin Genitourin Cancer. 2014 Aug;12(4):270-7. doi: 10.1016/j.clgc.2013.11.003. Epub 2013 Nov 14.

PMID:
24332507
16.

Commentary on association of clinical prostate and bladder cancers.

Nieder AM.

J Urol. 2008 May;179(5 Suppl):S6. doi: 10.1016/j.juro.2008.03.011. No abstract available.

PMID:
18405754
17.

[The prostate specific antigen: what can we learn from the American experience?].

Zhao XJ.

Zhonghua Yi Xue Za Zhi. 2005 Dec 14;85(47):3313-5. Chinese. No abstract available.

PMID:
16409833
18.

[Authorities in USA don't recommend screening for prostate cancer].

Bratt O.

Lakartidningen. 2011 Nov 16-22;108(46):2362. Swedish. No abstract available.

PMID:
22468374
19.

[Significance of current bio- and molecular-markers in urological cancers].

Shimazui T, Akaza H.

Gan To Kagaku Ryoho. 2004 Jul;31(7):1008-14. Review. Japanese.

PMID:
15272577

Supplemental Content

Support Center